Coprophagia—commonly described as ingestion of feces—and related re-ingestion behaviors are behavioral manifestations that can occur across animals and humans. In the context of “eating their vomit,” the seed concept centers on disordered ingestion of gastrointestinal contents and the associated risk of nutritional compromise, infection, and aspiration. While the phrase may be used casually online, clinically the relevant differential includes pica-like feeding behaviors, compulsive or habit-driven ingestion, eating-disorder spectrum symptoms, and neurodevelopmental or neuropsychiatric conditions that impair judgment and oral behavior.
In humans, harmful ingestion of vomitus or stool is uncommon but medically significant. The gastrointestinal tract contains a mixture of partially digested food, gastric acid, microorganisms, and sometimes blood or pathogens. Re-ingesting vomit may occur after induced or reflexive vomiting, after emesis from reflux, or in settings of severe nausea where the person repeatedly approaches emesis. Alternatively, it can reflect intentional sensory-seeking, contamination-related compulsions, or dysregulated self-care. Importantly, clinicians must distinguish between (1) a symptom driven by recurrent vomiting, (2) a behavior driven by sensory/behavioral reinforcement, and (3) a neuropsychiatric syndrome where ingestion is part of a broader pattern.
Potential medical mechanisms and drivers include neurologic impairment (e.g., developmental delay, autism spectrum disorder, traumatic brain injury), psychiatric illness (e.g., obsessive-compulsive phenomena, severe anxiety with contamination behaviors), and cognitive factors (limited awareness of consequences, impaired impulse control). Feeding and ingestive behaviors can also be shaped by reinforcement: the individual may experience temporary relief, sensory gratification, or reduction in distress after performing the act. In some cases, underlying gastrointestinal pathology—chronic nausea, rumination syndrome, gastroesophageal reflux disease, or gastroparesis—creates frequent episodes of emesis, increasing opportunities for ingestion-based behavior. Substance use can worsen nausea and alter executive function.
The health risks are substantial. Ingesting GI material can increase exposure to enteric pathogens, including bacteria and parasites, potentially leading to gastroenteritis, dysentery, or recurrent infections. Even if the individual survives an acute exposure, repeated ingestion can contribute to micronutrient malabsorption and weight changes. Another major hazard is aspiration: if vomiting occurs and contents are re-ingested or regurgitated, aspiration into the airway can trigger chemical pneumonitis or aspiration pneumonia. Dental enamel erosion and oral mucosal injury can occur from gastric acid contact, regardless of subsequent ingestion. Additionally, hematemesis or blood-tinged vomit ingestion raises concern for underlying upper GI bleeding.
Evaluation should be multidisciplinary. Medical assessment includes vital signs, hydration status, weight/BMI, and review of vomiting frequency and triggers. Clinicians should evaluate for red flags: persistent vomiting, inability to keep fluids down, severe abdominal pain, fever, blood in vomit or stool, black/tarry stools, neurologic deficits, and signs of dehydration. Laboratory testing may include complete blood count, electrolytes, renal function, inflammatory markers when indicated, and stool studies if infection is suspected. If there is concern for chronic GI disease, targeted testing (e.g., H. pylori testing, celiac screening, imaging, or endoscopy) may be appropriate based on age, symptoms, and risk factors.
Behavioral and psychiatric assessment should explore antecedents (hunger, nausea, distress, sensory triggers), consequences (relief, attention, avoidance), and comorbid conditions. Screening for eating-disorder patterns, compulsive symptoms, developmental concerns, and trauma history can clarify whether the behavior functions as a coping mechanism or a symptom. In neurodevelopmental populations, functional behavior analysis can identify maintaining variables and enable caregiver-centered interventions.
Evidence-based management typically addresses the root cause and reduces both medical and behavioral risk. For vomiting-driven triggers, treat the underlying GI disorder: reflux management, antiemetics when appropriate, dietary modifications, and investigation of motility disorders. For compulsive or habit-driven ingestion, behavioral therapy is central. Applied behavior analysis (ABA) principles or functional communication training may be used when the person cannot verbally identify needs or distress. Interventions often include stimulus control, competing response training, reinforcement of appropriate alternatives, and environmental safeguards (safe supervision, access restriction, and rapid post-emesis hygiene).
If psychiatric comorbidity is present, psychotherapy (e.g., CBT tailored to compulsions or anxiety) can reduce distress-driven behavior. Medication is not first-line for the ingestion behavior itself, but pharmacotherapy may be considered for comorbid conditions such as depression, anxiety, OCD-spectrum symptoms, or severe impulsivity under specialist care. Safety planning should explicitly cover aspiration risk and hydration, including prompt medical evaluation after repeated vomiting and guidance for caregivers or affected individuals.
Because re-ingestion behaviors are stigmatizing and can be hidden, compassionate, nonjudgmental care is essential to improve disclosure and adherence. Early recognition reduces morbidity by preventing infection, aspiration, and nutritional deterioration, and by treating coexisting vomiting disorders. Source: [Creator/Source]
Orpesy: @kindwest Eating their vomit 🤧. #breaking
— @Orpesy May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
